What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Cell biology, Biochemistry, Molecular biology, Cyclin B and Centrosome.
His Cell biology study combines topics from a wide range of disciplines, such as Ubiquitin ligase, Cyclin A and BBSome.
His Biochemistry research is multidisciplinary, incorporating perspectives in Cancer cell and Cancer.
In his research, Proto-oncogene tyrosine-protein kinase Src, Myristoylation, Oncogene and Phosphotyrosine-binding domain is intimately related to ABL, which falls under the overarching field of Molecular biology.
He works mostly in the field of Cyclin B, limiting it down to topics relating to Anaphase-promoting complex and, in certain cases, APC/C activator protein CDH1, Beta-Transducin Repeat-Containing Proteins and F-box protein.
His Mitosis research incorporates elements of Cell cycle and Mitotic exit.
His most cited work include:
- Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene (1218 citations)
- A Core Complex of BBS Proteins Cooperates with the GTPase Rab8 to Promote Ciliary Membrane Biogenesis (1033 citations)
- Mitosis in transition (689 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cell biology, Cilium, Molecular biology, Mitosis and Ubiquitin ligase.
His Cell biology research integrates issues from Cyclin B, Cell cycle, Cyclin A, Anaphase-promoting complex and Cyclin.
His research in Cyclin B tackles topics such as Cyclin A2 which are related to areas like Cyclin D.
His Cilium research includes themes of Ciliopathies, Signal transduction and Intraflagellar transport.
His Molecular biology research is multidisciplinary, incorporating elements of ABL and Phosphorylation.
His Mitosis research incorporates themes from Mitotic exit, Spindle pole body, Centrosome and PLK1.
He most often published in these fields:
- Cell biology (68.16%)
- Cilium (17.49%)
- Molecular biology (20.18%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (68.16%)
- Cilium (17.49%)
- Computational biology (5.38%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Cell biology, Cilium, Computational biology, KRAS and Stem cell.
Peter K. Jackson works in the field of Cell biology, namely G protein-coupled receptor.
The various areas that Peter K. Jackson examines in his Cilium study include Immunology, Subcellular localization, Organelle and Respiratory system.
His work deals with themes such as Plasma protein binding, Protein subunit and Ubiquitin ligase, which intersect with Subcellular localization.
Peter K. Jackson has included themes like RHOA, CRISPR, Neuroblastoma RAS viral oncogene homolog and Effector in his Computational biology study.
His biological study spans a wide range of topics, including Carcinogenesis, Cancer, Cancer research and Synthetic lethality.
Between 2017 and 2021, his most popular works were:
- CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities. (52 citations)
- Omega-3 Fatty Acids Activate Ciliary FFAR4 to Control Adipogenesis. (51 citations)
- ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs. (34 citations)
In his most recent research, the most cited papers focused on:
Peter K. Jackson spends much of his time researching Cilium, Cell biology, Cancer cell, Gene and Cancer research.
As part of one scientific family, Peter K. Jackson deals mainly with the area of Cilium, narrowing it down to issues related to the Respiratory system, and often Pathogenesis, Immunology, Lung and Organelle.
His study of G protein-coupled receptor is a part of Cell biology.
His research on Cancer cell also deals with topics like
- Melanoma that intertwine with fields like Cancer,
- Cyclin together with Regulator.
Within one scientific family, he focuses on topics pertaining to Effector under Gene, and may sometimes address concerns connected to Computational biology and CRISPR.
His Cancer research research is multidisciplinary, relying on both Proteomic Profiling, Stem cell, GNAS complex locus, Kinase and Transplantation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
